TRANSCRIPTIONAL SWITCHING MODEL FOR THE REGULATION OF TUMORIGENESIS AND METASTASIS BY THE HA-RAS ONCOGENE - TRANSCRIPTIONAL CHANGES IN THE HA-RAS TUMOR-SUPPRESSOR GENE LYSYL OXIDASE
- ZZ SU
- S YEMUL
- A ESTABROOK
- RM FRIEDMAN
- SG ZIMMER
- PB FISHER
Affiliations: COLUMBIA UNIV,COLL PHYS & SURG,CTR COMPREHENS CANC,INST CANC RES,DEPT PATHOL,NEW YORK,NY 10032. COLUMBIA UNIV,COLL PHYS & SURG,DEPT UROL,NEW YORK,NY 10032. COLUMBIA UNIV,COLL PHYS & SURG,DEPT SURG,NEW YORK,NY 10032. UNIFORMED SERV UNIV HLTH SCI,DEPT PATHOL,BETHESDA,MD 20814. LP MARKEY CANC CTR,DEPT MICROBIOL & IMMUNOL,LEXINGTON,KY 40536.
- Published online on: December 1, 1995 https://doi.org/10.3892/ijo.7.6.1279
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
A model system is described that allows an analysis of the molecular and biochemical changes associated with expression and suppression of the oncogenic and metastatic phenotype of cloned rat embryo fibroblast (CREF) cells. Ha-ras-transformed CREF cells are morphologically transformed, anchorage-independent and both tumorigenic and metastatic in athymic nude mice and syngeneic Fischer rats. Co-expression of the Ha-ras oncogene and Krev-1 tumor suppressor gene in CREF cells results in suppression of in vitro transformation. In contrast, Ha-ras/Krev-1 transformed CREF cells retain, with greatly extended latency periods, both tumorigenic and metastatic capabilities in athymic nude mice. The present study investigates changes in the Ha-ms suppressor gene, rrg (lysyl oxidase), during expression and suppression of the oncogenic phenotype in CREF cells. Nontumorigenic CREF cells and CREF cells transformed by the Ha-ras and Krev-1 gene that express a suppression in in vitro transformation contain elevated levels of lysyl oxidase mRNA and protein. In contrast, Ha-ms and Ha-ras/Krev-1 nude mouse tumor- and nude mouse lung metastasis-derived CREF cells contain reduced levels of lysyl oxidase mRNA and protein. Nuclear run-on assays indicate that suppression of lysyl oxidase expression in transformed subclones of CREF cells correlates with a reduction in transcription of the lysyl oxidase gene. Taken together, the current studies support a transcriptional switching model in which lysyl oxidase expression correlates directly with suppression of the Ka-ms-induced transformation phenotype and escape from oncogenic suppression correlates with a transcriptional silencing of the lysyl oxidase gene and decreased lysyl oxidase mRNA and protein.